1 Market Overview 1.1 Product Overview and Scope of Preimplantation Genetic Screening (PGS) Technology 1.2 Classification of Preimplantation Genetic Screening (PGS) Technology by Type 1.2.1 Overview: Global Preimplantation Genetic Screening (PGS) Technology Market Size by Type: 2017 Versus 2021 Versus 2028 1.2.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type in 2021 1.2.3 Next-generation Sequencing 1.2.4 Polymerase Chain Reaction 1.2.5 Fluorescence in Situ Hybridization 1.2.6 Comparative Genomic Hybridization 1.2.7 Single-nucleotide Polymorphism 1.3 Global Preimplantation Genetic Screening (PGS) Technology Market by Application 1.3.1 Overview: Global Preimplantation Genetic Screening (PGS) Technology Market Size by Application: 2017 Versus 2021 Versus 2028 1.3.2 Maternity Centers & Fertility Clinics 1.3.3 Hospitals 1.3.4 Research Laboratories & Academic Institutes 1.3.5 Others 1.4 Global Preimplantation Genetic Screening (PGS) Technology Market Size & Forecast 1.5 Global Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast by Region 1.5.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region: 2017 VS 2021 VS 2028 1.5.2 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region, (2017-2022) 1.5.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028) 1.5.4 Europe Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028) 1.5.5 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028) 1.5.6 South America Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028) 1.5.7 Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028) 1.6 Market Drivers, Restraints and Trends 1.6.1 Preimplantation Genetic Screening (PGS) Technology Market Drivers 1.6.2 Preimplantation Genetic Screening (PGS) Technology Market Restraints 1.6.3 Preimplantation Genetic Screening (PGS) Technology Trends Analysis 2 Company Profiles 2.1 Illumina 2.1.1 Illumina Details 2.1.2 Illumina Major Business 2.1.3 Illumina Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.1.4 Illumina Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.1.5 Illumina Recent Developments and Future Plans 2.2 Thermo Fisher Scientific 2.2.1 Thermo Fisher Scientific Details 2.2.2 Thermo Fisher Scientific Major Business 2.2.3 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.2.4 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans 2.3 Agilent Technologies 2.3.1 Agilent Technologies Details 2.3.2 Agilent Technologies Major Business 2.3.3 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.3.4 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.3.5 Agilent Technologies Recent Developments and Future Plans 2.4 PerkinElmer 2.4.1 PerkinElmer Details 2.4.2 PerkinElmer Major Business 2.4.3 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.4.4 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.4.5 PerkinElmer Recent Developments and Future Plans 2.5 Coopersurgical 2.5.1 Coopersurgical Details 2.5.2 Coopersurgical Major Business 2.5.3 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.5.4 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.5.5 Coopersurgical Recent Developments and Future Plans 2.6 Natera 2.6.1 Natera Details 2.6.2 Natera Major Business 2.6.3 Natera Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.6.4 Natera Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.6.5 Natera Recent Developments and Future Plans 2.7 Takara Bio 2.7.1 Takara Bio Details 2.7.2 Takara Bio Major Business 2.7.3 Takara Bio Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.7.4 Takara Bio Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.7.5 Takara Bio Recent Developments and Future Plans 2.8 Oxford Gene Technology 2.8.1 Oxford Gene Technology Details 2.8.2 Oxford Gene Technology Major Business 2.8.3 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.8.4 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.8.5 Oxford Gene Technology Recent Developments and Future Plans 2.9 INVICTA 2.9.1 INVICTA Details 2.9.2 INVICTA Major Business 2.9.3 INVICTA Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.9.4 INVICTA Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.9.5 INVICTA Recent Developments and Future Plans 2.10 Genea 2.10.1 Genea Details 2.10.2 Genea Major Business 2.10.3 Genea Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.10.4 Genea Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.10.5 Genea Recent Developments and Future Plans 2.11 Progenesis 2.11.1 Progenesis Details 2.11.2 Progenesis Major Business 2.11.3 Progenesis Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.11.4 Progenesis Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.11.5 Progenesis Recent Developments and Future Plans 2.12 Igenomix 2.12.1 Igenomix Details 2.12.2 Igenomix Major Business 2.12.3 Igenomix Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.12.4 Igenomix Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.12.5 Igenomix Recent Developments and Future Plans 2.13 Reproductive Health and Wellness Center 2.13.1 Reproductive Health and Wellness Center Details 2.13.2 Reproductive Health and Wellness Center Major Business 2.13.3 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product and Solutions 2.13.4 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022) 2.13.5 Reproductive Health and Wellness Center Recent Developments and Future Plans 3 Market Competition, by Players 3.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Share by Players (2019, 2020, 2021, and 2022) 3.2 Market Concentration Rate 3.2.1 Top 3 Preimplantation Genetic Screening (PGS) Technology Players Market Share in 2021 3.2.2 Top 10 Preimplantation Genetic Screening (PGS) Technology Players Market Share in 2021 3.2.3 Market Competition Trend 3.3 Preimplantation Genetic Screening (PGS) Technology Players Head Office, Products and Services Provided 3.4 Preimplantation Genetic Screening (PGS) Technology Mergers & Acquisitions 3.5 Preimplantation Genetic Screening (PGS) Technology New Entrants and Expansion Plans 4 Market Size Segment by Type 4.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Market Share by Type (2017-2022) 4.2 Global Preimplantation Genetic Screening (PGS) Technology Market Forecast by Type (2023-2028) 5 Market Size Segment by Application 5.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2017-2022) 5.2 Global Preimplantation Genetic Screening (PGS) Technology Market Forecast by Application (2023-2028) 6 North America by Country, by Type, and by Application 6.1 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028) 6.2 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028) 6.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country 6.3.1 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2028) 6.3.2 United States Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 6.3.3 Canada Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 6.3.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 7 Europe by Country, by Type, and by Application 7.1 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028) 7.2 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028) 7.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country 7.3.1 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2028) 7.3.2 Germany Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 7.3.3 France Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 7.3.4 United Kingdom Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 7.3.5 Russia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 7.3.6 Italy Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 8 Asia-Pacific by Region, by Type, and by Application 8.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028) 8.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028) 8.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region 8.3.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2017-2028) 8.3.2 China Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 8.3.3 Japan Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 8.3.4 South Korea Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 8.3.5 India Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 8.3.6 Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 8.3.7 Australia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 9 South America by Country, by Type, and by Application 9.1 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028) 9.2 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028) 9.3 South America Preimplantation Genetic Screening (PGS) Technology Market Size by Country 9.3.1 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2028) 9.3.2 Brazil Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 9.3.3 Argentina Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 10 Middle East & Africa by Country, by Type, and by Application 10.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028) 10.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028) 10.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country 10.3.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2028) 10.3.2 Turkey Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 10.3.3 Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 10.3.4 UAE Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028) 11 Research Findings and Conclusion 12 Appendix 12.1 Methodology 12.2 Research Process and Data Source 12.3 Disclaimer

List of Tables Table 1. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Type, (USD Million), 2017 VS 2021 VS 2028 Table 2. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Application, (USD Million), 2017 VS 2021 VS 2028 Table 3. Global Market Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028) Table 4. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Region (2017-2022) Table 5. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2023-2028) Table 6. Illumina Corporate Information, Head Office, and Major Competitors Table 7. Illumina Major Business Table 8. Illumina Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 9. Illumina Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors Table 11. Thermo Fisher Scientific Major Business Table 12. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 13. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors Table 15. Agilent Technologies Major Business Table 16. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 17. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 18. PerkinElmer Corporate Information, Head Office, and Major Competitors Table 19. PerkinElmer Major Business Table 20. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 21. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 22. Coopersurgical Corporate Information, Head Office, and Major Competitors Table 23. Coopersurgical Major Business Table 24. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 25. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 26. Natera Corporate Information, Head Office, and Major Competitors Table 27. Natera Major Business Table 28. Natera Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 29. Natera Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 30. Takara Bio Corporate Information, Head Office, and Major Competitors Table 31. Takara Bio Major Business Table 32. Takara Bio Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 33. Takara Bio Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 34. Oxford Gene Technology Corporate Information, Head Office, and Major Competitors Table 35. Oxford Gene Technology Major Business Table 36. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 37. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 38. INVICTA Corporate Information, Head Office, and Major Competitors Table 39. INVICTA Major Business Table 40. INVICTA Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 41. INVICTA Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 42. Genea Corporate Information, Head Office, and Major Competitors Table 43. Genea Major Business Table 44. Genea Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 45. Genea Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 46. Progenesis Corporate Information, Head Office, and Major Competitors Table 47. Progenesis Major Business Table 48. Progenesis Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 49. Progenesis Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 50. Igenomix Corporate Information, Head Office, and Major Competitors Table 51. Igenomix Major Business Table 52. Igenomix Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 53. Igenomix Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 54. Reproductive Health and Wellness Center Corporate Information, Head Office, and Major Competitors Table 55. Reproductive Health and Wellness Center Major Business Table 56. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product and Solutions Table 57. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 58. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Players (2019, 2020, 2021, and 2022) Table 59. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Players (2019, 2020, 2021, and 2022) Table 60. Breakdown of Preimplantation Genetic Screening (PGS) Technology by Company Type (Tier 1, Tier 2 and Tier 3) Table 61. Preimplantation Genetic Screening (PGS) Technology Players Head Office, Products and Services Provided Table 62. Preimplantation Genetic Screening (PGS) Technology Mergers & Acquisitions in the Past Five Years Table 63. Preimplantation Genetic Screening (PGS) Technology New Entrants and Expansion Plans Table 64. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Type (2017-2022) Table 65. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type (2017-2022) Table 66. Global Preimplantation Genetic Screening (PGS) Technology Revenue Forecast by Type (2023-2028) Table 67. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) Table 68. Global Preimplantation Genetic Screening (PGS) Technology Revenue Forecast by Application (2023-2028) Table 69. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million) Table 70. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million) Table 71. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million) Table 72. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million) Table 73. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2022) & (USD Million) Table 74. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2023-2028) & (USD Million) Table 75. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million) Table 76. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million) Table 77. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million) Table 78. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million) Table 79. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2022) & (USD Million) Table 80. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2023-2028) & (USD Million) Table 81. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million) Table 82. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million) Table 83. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million) Table 84. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million) Table 85. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2017-2022) & (USD Million) Table 86. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2023-2028) & (USD Million) Table 87. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million) Table 88. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million) Table 89. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million) Table 90. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million) Table 91. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2022) & (USD Million) Table 92. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2023-2028) & (USD Million) Table 93. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million) Table 94. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million) Table 95. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million) Table 96. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million) Table 97. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2022) & (USD Million) Table 98. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2023-2028) & (USD Million) List of Figures Figure 1. Preimplantation Genetic Screening (PGS) Technology Picture Figure 2. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type in 2021 Figure 3. Next-generation Sequencing Figure 4. Polymerase Chain Reaction Figure 5. Fluorescence in Situ Hybridization Figure 6. Comparative Genomic Hybridization Figure 7. Single-nucleotide Polymorphism Figure 8. Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application in 2021 Figure 9. Maternity Centers & Fertility Clinics Picture Figure 10. Hospitals Picture Figure 11. Research Laboratories & Academic Institutes Picture Figure 12. Others Picture Figure 13. Global Preimplantation Genetic Screening (PGS) Technology Market Size, (USD Million): 2017 VS 2021 VS 2028 Figure 14. Global Preimplantation Genetic Screening (PGS) Technology Revenue and Forecast (2017-2028) & (USD Million) Figure 15. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2017-2028) Figure 16. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region in 2021 Figure 17. North America Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028) Figure 18. Europe Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028) Figure 19. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028) Figure 20. South America Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028) Figure 21. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028) Figure 22. Preimplantation Genetic Screening (PGS) Technology Market Drivers Figure 23. Preimplantation Genetic Screening (PGS) Technology Market Restraints Figure 24. Preimplantation Genetic Screening (PGS) Technology Market Trends Figure 25. Illumina Recent Developments and Future Plans Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans Figure 27. Agilent Technologies Recent Developments and Future Plans Figure 28. PerkinElmer Recent Developments and Future Plans Figure 29. Coopersurgical Recent Developments and Future Plans Figure 30. Natera Recent Developments and Future Plans Figure 31. Takara Bio Recent Developments and Future Plans Figure 32. Oxford Gene Technology Recent Developments and Future Plans Figure 33. INVICTA Recent Developments and Future Plans Figure 34. Genea Recent Developments and Future Plans Figure 35. Progenesis Recent Developments and Future Plans Figure 36. Igenomix Recent Developments and Future Plans Figure 37. Reproductive Health and Wellness Center Recent Developments and Future Plans Figure 38. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Players in 2021 Figure 39. Preimplantation Genetic Screening (PGS) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021 Figure 40. Global Top 3 Players Preimplantation Genetic Screening (PGS) Technology Revenue Market Share in 2021 Figure 41. Global Top 10 Players Preimplantation Genetic Screening (PGS) Technology Revenue Market Share in 2021 Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022) Figure 43. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type in 2021 Figure 44. Global Preimplantation Genetic Screening (PGS) Technology Market Share Forecast by Type (2023-2028) Figure 45. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Application in 2021 Figure 46. Global Preimplantation Genetic Screening (PGS) Technology Market Share Forecast by Application (2023-2028) Figure 47. North America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028) Figure 48. North America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028) Figure 49. North America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2017-2028) Figure 50. United States Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 51. Canada Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. Mexico Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 53. Europe Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028) Figure 54. Europe Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028) Figure 55. Europe Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2017-2028) Figure 56. Germany Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 57. France Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. United Kingdom Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. Russia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Italy Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028) Figure 62. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028) Figure 63. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2017-2028) Figure 64. China Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 65. Japan Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 66. South Korea Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. India Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 68. Southeast Asia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 69. Australia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 70. South America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028) Figure 71. South America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028) Figure 72. South America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2017-2028) Figure 73. Brazil Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 74. Argentina Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028) Figure 76. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028) Figure 77. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2017-2028) Figure 78. Turkey Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 79. Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 80. UAE Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million) Figure 81. Methodology Figure 82. Research Process and Data Source

Illumina Thermo Fisher Scientific Agilent Technologies PerkinElmer Coopersurgical Natera Takara Bio Oxford Gene Technology INVICTA Genea Progenesis Igenomix Reproductive Health and Wellness Center